Estrogen-Only Hormone Therapy and Dementia Risk

Does Estrogen-Only Hormone Therapy Lower Dementia Risk?

The findings reported by Harvard Health add to an unsettled body of research on menopausal hormone therapy and brain health. Estrogen influences blood vessels, inflammation, glucose metabolism and signaling systems involved in memory, providing biologically plausible pathways through which treatment might affect cognitive aging. However, people who use hormone therapy can differ from nonusers in education, income, healthcare access, cardiovascular health and other factors that also influence dementia risk.

Randomized evidence requires a more cautious interpretation. The Women's Health Initiative Memory Study evaluated oral conjugated equine estrogen in women aged 65 to 79 who had undergone hysterectomy and did not demonstrate dementia prevention. Its findings cannot be directly applied to every formulation, dose, route of administration or treatment started closer to menopause, but they remain an important reason not to prescribe estrogen solely to prevent cognitive decline.

Why Might Treatment Timing and Formulation Matter?

Researchers have proposed a timing hypothesis in which hormone therapy begun near the onset of menopause could have different effects from therapy started many years later. Age-related changes in blood vessels and the brain may alter the balance between potential benefits and harms. This hypothesis remains under investigation and should not be treated as proof that early hormone therapy prevents Alzheimer's disease or other dementias.

Estrogen-only therapy is also clinically distinct from estrogen combined with a progestogen. Systemic estrogen without endometrial protection is generally reserved for people who no longer have a uterus because unopposed estrogen can increase the risk of endometrial hyperplasia and cancer. Oral and transdermal products also differ in their effects on clotting and metabolism, making individualized treatment assessment essential.

Should Menopausal Hormones Be Used to Prevent Dementia?

Hormone therapy remains an effective treatment for bothersome hot flashes, night sweats and related menopausal symptoms, while local vaginal estrogen can treat genitourinary symptoms with relatively limited systemic exposure. Decisions about systemic treatment should consider symptom severity, age, time since menopause, treatment formulation and personal risks involving blood clots, stroke, cardiovascular disease and hormone-sensitive cancers.

Patients already using prescribed estrogen should not stop treatment abruptly because of a single news report. A clinician can review why the medicine was prescribed, whether the current dose and route remain appropriate, and whether ongoing treatment still offers more benefit than risk. Established approaches to supporting brain health include controlling blood pressure and diabetes, avoiding tobacco, staying physically active, addressing hearing loss and maintaining social engagement.